cgb-400
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 26, 2018 (NCT04508205)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04886739 | Phase 2 | May 7, 2021 | CAGE Bio Inc., ethica Clinical Research Inc. |
| NCT04508205 | Phase 1 | Oct 26, 2018 | CAGE Bio Inc., ethica Clinical Research Inc. |
| NCT04508660 | Phase 1 | Oct 26, 2018 | CAGE Bio Inc., ethica Clinical Research Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CAGE Bio Inc. | For profit | 3 | 3 | 2 | 2018 |
| ethica Clinical Research Inc. | For profit | 3 | 0 | 2 | 2018 |
2 organizations
Page 1 / 1